The front-line therapy of macular edema associated with diabetic retinopathy or retinal vascular occlusions is anti-VEGF therapy, delivered into the eye by intravitreal injection and sometimes augmented with intravitreal corticosteroid and/or retinal laser photocoagulation (24–26). Here, VEGFA is linked to macular retinal edema.